PEDIATRIC BLOOD & CANCER

简称 PEDIATR BLOOD CANCER ·UNITED STATES ·出版周期 Monthly ·年均收录 344 篇

2.3

最新影响因子

11.30%

自引率

约25%

投稿难度

平均1.5月

审稿周期

期刊简介

PEDIATRIC BLOOD & CANCER是一本专注于儿科血液学和肿瘤学研究的国际期刊，ISSN号为1545-5009，由Wiley出版商出版，出版地为美国，出版周期为月刊。该期刊的影响因子根据年份不同有所波动，近年来保持在2-3左右，属于SCI收录期刊，中科院分区通常位于医学大类3区或4区，具体分区需参考当年数据，该期刊为非开放获取（非OA）期刊。杂志的发文特点集中于儿童血液疾病和癌症的临床与基础研究，涵盖白血病、淋巴瘤、实体瘤、造血干细胞移植、遗传性血液病等领域，注重多学科交叉研究和临床实践应用。杂志质量在儿科血液肿瘤领域具有一定影响力，审稿流程较为严格，但影响因子相对中等，可能存在投稿竞争激烈或审稿周期较长的风险，适合从事儿科血液肿瘤研究的学者投稿。

影响因子趋势

近期发表

10.1002/mpo.v73.10 2026-08-25

A Three‐Component Immune Framework Stratifies Treatment Response and Escalation in Pediatric Hemophagocytic Lymphohistiocytosis: A Prospective Single‐Center Cohort Study 2026-09-03

Safety and Effectiveness of a High‐Dose, Tailored Tissue Plasminogen Activator Therapy Protocol: A Joint Pediatric Hematology and Cardiac ICU Quality Improvement Initiative Analysis 2026-09-03

Pain Management After Pediatric Hematopoietic Cell Transplantation: A Narrative Review of Pain Phenotypes, Assessment, and Multimodal Care 2026-09-03

Global Efforts to Reduce Paediatric Cancer Care Disparities in Radiotherapy: A Decade Change 2026-09-02

Pain in Children and Adolescents With Low‐Flow Vascular Malformation and Its Relation to Thrombosis 2026-09-03

10.1002/mpo.v73.9 2026-08-26

Provider and Parent Perspectives on Prioritizing the “Asking and Monitoring” Pediatric Cancer Psychosocial Standards of Care 2026-08-31

Revisiting Busulfan–Melphalan Sequencing in Paediatric Solid Tumours: A Pharmacokinetic Signal Beyond Conditioning Sequence 2026-08-27

Pediatric Mediastinal Gray Zone Lymphoma With Germline <i>TET2</i> Heterozygous Variant 2026-08-27